Your cart

Your cart is empty

THIS CONTENT IS EXCLUSIVE TO SAGED MEMBERS.🔒

Please log in to your member account or sign up to view these contents in full.

Renal Conditions and Medical Cannabis
Renal Conditions and Medical Cannabis

Renal Conditions and Medical Cannabis

1 LEARNING CREDITS

    • Overview

      Renal conditions can be challenging to manage due to the complexity of symptoms, limitations in treatment options and comorbidities.¹

      Preliminary and emerging research has demonstrated medical cannabis' therapeutic potential for treating some symptoms of renal conditions, particularly neuropathic pain and uremia-induced pruritis.²

      Though it is theorised that medical cannabis treatment may present risks to those with renal conditions – particularly concerning drug-drug-interactions.³

      As medical cannabis use continues to grow, healthcare professionals should stay informed about medical cannabis treatment applications in renal conditions, and equipped to provide the best evidence-based guidance.⁴

      Preview this module by watching the video above.

      Estimated Duration: 1 hour

      Access Duration: 12 months from date of purchase

      Learning Outcomes

      Upon completion of this module, you’ll be able to:

      • Describe the physiology and key functions of the kidneys
      • Describe the pathophysiology of chronic kidney disease (CKD), acute kidney injury (AKI), autosomal dominant polycystic kidney disease (ADPKD) and renal cancer and recommended conventional treatment options
      • Describe medical cannabis' therapeutic potential for treating symptoms of renal conditions
      • Identify risks, risk management strategies and general considerations of medical cannabis treatment for individuals with renal conditions

      References

      1. Webster AC, Nagler EV, Morton RL, Masson P. Chronic kidney disease. The Lancet. 2017;389(10075):1238-1252. doi:https://doi.org/10.1016/s0140-6736(16)32064-5
      2. Ho C, Martinusen D, Lo C. A Review of Cannabis in Chronic Kidney Disease Symptom Management. Canadian Journal of Kidney Health and Disease. 2019;6:205435811982839. doi:https://doi.org/10.1177/2054358119828391
      3. Lappin J. Drug Interactions with Cannabis. Society of Cannabis Clinicians. Published July 10, 2024. Accessed February 27, 2025. https://www.cannabisclinicians.org/2024/07/10/drug-interactions-with-cannabis/
      4. Rein JL. The Nephrologistʼs Guide to Cannabis and Cannabinoids. Current Opinion in Nephrology and Hypertension. 2020;29(2):248-257. doi:https://doi.org/10.1097/mnh.0000000000000590

    Overview

    Renal conditions can be challenging to manage due to the complexity of symptoms, limitations in treatment options and comorbidities.¹

    Preliminary and emerging research has demonstrated medical cannabis' therapeutic potential for treating some symptoms of renal conditions, particularly neuropathic pain and uremia-induced pruritis.²

    Though it is theorised that medical cannabis treatment may present risks to those with renal conditions – particularly concerning drug-drug-interactions.³

    As medical cannabis use continues to grow, healthcare professionals should stay informed about medical cannabis treatment applications in renal conditions, and equipped to provide the best evidence-based guidance.⁴

    Preview this module by watching the video above.

    Estimated Duration: 1 hour

    Access Duration: 12 months from date of purchase

    Learning Outcomes

    Upon completion of this module, you’ll be able to:

    • Describe the physiology and key functions of the kidneys
    • Describe the pathophysiology of chronic kidney disease (CKD), acute kidney injury (AKI), autosomal dominant polycystic kidney disease (ADPKD) and renal cancer and recommended conventional treatment options
    • Describe medical cannabis' therapeutic potential for treating symptoms of renal conditions
    • Identify risks, risk management strategies and general considerations of medical cannabis treatment for individuals with renal conditions

    References

    1. Webster AC, Nagler EV, Morton RL, Masson P. Chronic kidney disease. The Lancet. 2017;389(10075):1238-1252. doi:https://doi.org/10.1016/s0140-6736(16)32064-5
    2. Ho C, Martinusen D, Lo C. A Review of Cannabis in Chronic Kidney Disease Symptom Management. Canadian Journal of Kidney Health and Disease. 2019;6:205435811982839. doi:https://doi.org/10.1177/2054358119828391
    3. Lappin J. Drug Interactions with Cannabis. Society of Cannabis Clinicians. Published July 10, 2024. Accessed February 27, 2025. https://www.cannabisclinicians.org/2024/07/10/drug-interactions-with-cannabis/
    4. Rein JL. The Nephrologistʼs Guide to Cannabis and Cannabinoids. Current Opinion in Nephrology and Hypertension. 2020;29(2):248-257. doi:https://doi.org/10.1097/mnh.0000000000000590

    CONTENT EXCLUSIVE TO MEMBERS

    LOG IN OR SIGN UP